Hikma, Cipla Cut Deals In Pfizer Heart Drug Patent Case
Hikma Pharmaceuticals PLC and Cipla Ltd. have reached settlements with Pfizer Inc. in a case over the two defendants' efforts to create generic versions of the heart medication Vyndamax....To view the full article, register now.
Already a subscriber? Click here to view full article